| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Health Care Equipment & Supplies (Health Care sector), STAA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 16.12M | - | - | |
| CEO | 94.0K | - | - | |
| CFO | 41.5K | - | - | |
| Other | 22.8K | $563.0K | - | |
| Dir | 11.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2021 | Broadwood Partners, L.P.61 | 10% Owner | Sell | 266,278 | $146.71 | $39,065,520.85 | -2.9% | +4.0% | -54.7% | |
| May 24, 2021 | Blickensdoerfer Hans-Martin71 | Sr. VP, Comm. Ops, China | Sale+OE | 100,000 | $130.30 | $13,029,549.10 | -48.0% | +2.5% | -55.8% | |
| May 24, 2021 | Francese James E69 | Sr. VP, Comm. Ops., Na, Apac | Sale+OE | 29,761 | $128.58 | $3,826,642.63 | -36.1% | +2.5% | -55.8% | |
| May 12, 2021 | Hansen Graydon C. | Sr. VP, Global Operations | Sale+OE | 16,606 | $111.32 | $1,848,583.69 | -65.2% | +29.4% | -51.1% | |
| May 11, 2021 | Mason Caren L61 | President &CEO | Sale+OE | 107,000 | $115.29 | $12,336,030.00 | -62.8% | +35.1% | -55.6% | |
| May 10, 2021 | Hayashida Jon K. | VP, Global Clinical, Medical | Sale+OE | 12,109 | $124.25 | $1,504,560.58 | -42.6% | +36.9% | -52.6% | |
| May 10, 2021 | Francese James E69 | Sr. VP, Comm. Ops., Na, Apac | Sale+OE | 11,583 | $125.72 | $1,456,214.76 | -18.0% | +36.9% | -52.6% | |
| May 10, 2021 | Holliday Keith71 | Chief Technology Officer | Sell | 8,874 | $125.83 | $1,116,615.42 | -28.1% | +36.9% | -52.6% | |
| Apr 26, 2021 | Broadwood Partners, L.P.61 | 10% Owner | Sell | 117,906 | $133.61 | $15,753,764.90 | -1.2% | -6.9% | -55.6% | |
| Mar 22, 2021 | Hayashida Jon K. | VP, Global Clinical, Medical | Sell | 1,103 | $96.37 | $106,296.11 | -10.2% | +51.5% | -22.6% |